Loading clinical trials...
Loading clinical trials...
Effectiveness and Tolerability of Tarka in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus, Not Controlled on Single-drug Therapy: A Multicountry, Multicenter, Post-marketing Observational Study in the Routine Clinical Use
Conditions
Locations
898
Bulgaria
Site Reference ID/Investigator# 29197
Haskovo, Bulgaria
Site Reference ID/Investigator# 29685
Pleven, Bulgaria
Site Reference ID/Investigator# 29682
Plovdiv, Bulgaria
Site Reference ID/Investigator# 29686
Plovdiv, Bulgaria
Site Reference ID/Investigator# 29097
Sofia, Bulgaria
Site Reference ID/Investigator# 28954
Sofia, Bulgaria
Start Date
October 1, 2007
Primary Completion Date
March 1, 2010
Completion Date
March 1, 2010
Last Updated
May 9, 2011
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Abbott
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions